Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Restless Legs Syndrome/Willis Ekbom Disease -

Restless Legs Syndrome/Willis Ekbom Disease

Long-Term Consequences and Management
Buch | Hardcover
287 Seiten
2017 | 1st ed. 2017
Springer-Verlag New York Inc.
978-1-4939-6775-9 (ISBN)
CHF 179,70 inkl. MwSt
  • Versand in 10-15 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
Due to the fact that Restless Legs Syndrome/Willis-Ekbom Disease is usually a chronic condition, this book aims to provide physicians with the necessary tools for the long-term management of patients with RLS. The first part of the book addresses the various comorbidities and long-term consequences of RLS on life quality, sleep, cognitive, psychiatric and cardiovascular systems, while the second part focuses on the management of long-term treatment and the drug-induced complications in primary RLS and in special populations. Written by experts in the field, this practical resource offers a high-quality, long-term management of RLS for neurologists, sleep clinicians, pulmonologists and other healthcare professionals.

Mauro Manconi, MD, PhDSleep and Epilepsy CenterNeurocenter of Southern SwitzerlandCivic HospitalLugano, Switzerland Diego García-Borreguero, MD, PhDSleep Research InstituteMadrid, Spain

I. Long Term Health Consequences of Restless Legs Syndrome/Willis-Ekbom Disease.- 1. Mental Health Disorders Associated with RLS.- 2. Sleep Impact: Insomnia, Hypersomnia, Sleep Attacks, and Circadian Disorders.- 3. Cognitive Functioning.- 4. Health Related Quality of Life and Depression/Anxiety Symptom Measures for the Assessment of Treatment in Restless Legs Syndrome/Willis-Ekbom Disease.- 5. Epidemiologic Evidence in Cardiovascular Disease.- 6. Heart Rate and Blood Pressure Changes Associated with Periodic Limb Movements.- 7. Willis-Ekbom Disease, Periodic Limb Movements of Sleep, and Cardiovascular Disease: Putative Mechanisms and Implications for Long-Term Treatment.- 8. Peripheral Muscle Changes.- 9. Outcome and Mortality in Renal Failure-Related RLS.- II. Long Term Management of Restless Legs Syndrome/Willis-Ekbom Disease.- 10. Long Term Pharmacological Treatment.- 11. Augmentation: Criteria, Prevalence, and DifferentialDiagnosis.- 12. Treatment Options When Short-Acting Dopamine Agonists Fail or Cause Augmentation: Switching or Adding Medications.- 13. Management of Augmentation.- 14. Managing Concurrent Medications.- 15. Impulsive Behaviors: Definition, Prevalence, Neurobiology, and Management.- 16. Impulse Control Behavior in Movement Disorders: Focus on Restless Leg Syndrome.- 17. Management of RLS During Pregnancy.- 18. Management of RLS in Children (Unique Features).

Erscheinungsdatum
Zusatzinfo 10 Illustrations, color; 6 Illustrations, black and white; XIV, 287 p. 16 illus., 10 illus. in color.
Verlagsort New York
Sprache englisch
Maße 155 x 235 mm
Themenwelt Medizinische Fachgebiete Innere Medizin Kardiologie / Angiologie
Medizin / Pharmazie Medizinische Fachgebiete Neurologie
Medizin / Pharmazie Medizinische Fachgebiete Psychiatrie / Psychotherapie
Medizin / Pharmazie Studium
Schlagworte Cardiovascular Disease • limb movement • quality of life • restless leg syndrome • willis ekbom disease
ISBN-10 1-4939-6775-4 / 1493967754
ISBN-13 978-1-4939-6775-9 / 9781493967759
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
in Fällen, Fragen und Antworten

von Christoph Spes; Volker Klauss; Sibylle Tönjes

Buch | Softcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 124,60
Diagnostik und interventionelle Therapie | 2 Bände

von Raimund Erbel; Michael Haude; Philipp Kahlert; Björn Plicht …

Buch (2024)
Deutscher Ärzteverlag
CHF 489,95